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Cell-surface glycoprotein receptors have varying numbers of N-glycan sites. In this issue 
of Cell, Lau et al. (2007) report that increasing intracellular UDP-GlcNAc leads to increased 
branching of N-glycans, increased receptor association with cell-surface galectin-3, and 
enhanced signaling. They also show that the kinetics of this response differ between 
growth-promoting receptors, which have 8–16 N-glycans, and those that induce growth 
arrest, which have very few N-glycans, suggesting that hexosamine flux may regulate the 
transition from growth to arrest.There is a large complement of 
N-glycans linked via asparagine in 
N-X-S/T motifs to glycoproteins of 
the plasma membrane, the molecular 
frontier of the cell. Glycoproteins may 
have many sites of N-glycan addition, 
and each site has the potential to be 
modified by tens of different N-gly-
can structures. This heterogeneity, 
which leads to multiple glycoforms of 
an individual glycoprotein, has tradi-
tionally been dismissed as a tolerable 
sloppiness in biosynthesis because 
N-glycans perform general functions 
in the folding, secretion, and solubil-
ity of glycoproteins. However, gene-
targeting experiments have identified 
dramatic biological consequences 
of abolishing or reducing N-glycan 
branching in the Golgi (Lowe and 
Marth, 2003). The paper by Lau et al. 
(2007) now suggests a method to the 
madness of N-glycan complexity.
The authors’ hypothesis links the 
evolutionary origins of the number 
of N-glycan sites in receptors that 
regulate growth with metabolic flux 
through the hexosamine pathway 
that regulates N-glycan branching in 
the Golgi. They show that changes in 
this flux affect the residence time of 
receptors on the cell surface by mod-
ulating the interactions of branched 
N-glycans with galectin-3, a glycan-
binding protein. The galectin-3 lattice 
restricts endocytosis and thus hin-
ders the downregulation of signaling. 
Their findings suggest that growth-promoting receptors, which have high 
numbers of N-glycans, and receptors 
that cause growth arrest, which have 
few N-glycans, are affected differ-
ently by metabolic flux through the 
hexosamine pathway. The differential 
association of growth- and arrest-
promoting receptors with the galectin 
lattice is proposed as a mechanism 
to achieve balance between cellular 
growth and arrest prior to cell differ-
entiation. However, to appreciate this 
big picture, it is helpful to start at the 
beginning.
The Dennis lab originally showed 
that tumor cells with a mutation in 
a gene needed to synthesize a par-
ticular branch in complex N-glycans 
make few tumors, and the tumors that 
do arise metastasize poorly (Den-
nis et al., 1987). Similar effects were 
seen in mice with the same mutation 
expressing Polyoma middle T anti-
gen (PyMT)(Granovsky et al., 2000). 
The defective gene in each case was 
Mgat5, which codes for the glycosyl-
transferase Mgat5 (or GlcNAc-TV) 
that catalyses the addition of a β1,6-
linked GlcNAc to form a tri- or tetra-
antennary N-glycan (Figure 1A). In 
general, the more GlcNAc branches 
per N-glycan, the more Gal residues 
are added and elongated to form 
polylactosamine [Galβ1,4GlcNAc]n. 
Galectins bind Gal and form specific 
crosslinked lattices with glycopro-
teins (Brewer et al., 2002). Glycopro-
tein receptors in wild-type tumor cells Cell 1associate with galectin-3 at the cell 
surface, whereas the same receptors 
in cells lacking Mgat5 reside largely 
in endosomes (Partridge et al., 2004). 
The effects of loss of Mgat5 on sig-
naling strength are much greater for 
receptors with many N-glycan sites 
(such as EGFR, PDGFR, FGFR, and 
IGFR) versus those with few N-gly-
cans (such as TGFβRI and TGFβRII). 
Differential cell-surface residency of 
growth-modulating receptors could 
explain the differences in cell prolifer-
ation, cytoskeletal organization, sig-
nal transduction, and T cell activation 
between wild-type cells and those 
lacking Mgat5 (Demetriou et al., 2001; 
Lagana et al., 2006; Partridge et al., 
2004). The new work by Lau et al. 
(2007) provides a mechanistic basis 
for the differences in N-glycan site 
multiplicity (n) between growth-pro-
moting receptors (which have a high 
n) and receptors that promote growth 
arrest (which have a low n).
The paper shows that the poor sig-
naling responses to EGF or TGFβ of 
PyMT tumor cells lacking Mgat5 are 
largely overcome by growth in the 
presence of high concentrations of N-
acetylglucosamine (GlcNAc). Increas-
ing intracellular UDP-GlcNAc promotes 
a switch-like increase in Golgi N-gly-
can branching, enhances the associa-
tion of EGFR or TGFβR with galectin-3 
promoting cell-surface residency, and 
leads to an increase in signaling. How-
ever, with increasing UDP-GlcNAc, the 29, April 6, 2007 ©2007 Elsevier Inc. 27
Figure 1. N-Glycan Branching and Growth Control
The branched N-glycans attached at N-X-S/T sites in Mgat5+/+ and Mgat5−/− PyMT tumor cells are shown on the left. Cells lacking Mgat5 cannot 
add the branch initiated by a β1,6GlcNAc (green arrows) and so they cannot make the most complex types of branched N-glycans. Mono, bi, tri, 
and tetra refer to the number of branches in an N-glycan. On the right is a diagram of the response of Mgat5−/− tumor cells to metabolic flux. Growth 
of cells in increasing GlcNAc (x axis) causes an increase in N-glycan branching, increased cell-surface expression of glycoprotein receptors due 
to enhanced interactions with galectin-3, and increased signaling (y axis). The kinetics of signaling differ for growth-promoting receptors that have 
high numbers of N-glycans (hyperbolic), and growth arrest receptors that have low numbers of N-glycans (switch-like). NuMG and CHO cells exhibit 
similar results but Mgat5+/+ tumor cells have such highly branched N-glycans that they do not exhibit switch-like responses to increases in intracel-
lular UDP-GlcNAc.signaling response to EGF is hyper-
bolic, whereas the response to TGFβ 
is switch-like (Figure 1B). Although the 
same growth conditions also enhance 
signaling in tumor cells that express 
Mgat5, the kinetics are not switch-like 
and instead are hyperbolic. Thus, tumor 
cells lacking Mgat5 reveal that N-glycan 
branching in the Golgi may be ultrasen-
sitive to metabolic flux through the hex-
osamine pathway. Furthermore, signal-
ing kinetics in those cells also depend 
on the multiplicity of N-glycans in a 
receptor. The kinetics are hyperbolic 
for the growth-promoting receptors 
EGFR, PDGFR, IGFR, and FGFR (8–16 
N-glycans) and switch-like for TGFβR, 
which induces growth arrest, and also 
for GLUT4, which regulates glucose 
transport (1–2 N-glycans). GLUT2 also 
requires branched N-glycans to func-
tion at the cell surface (Ohtsubo et al., 
2005). The kinetics of the signaling 
responses hold true in CHO and NuMG 
cells, whereas the CHO mutant Lec1 
that makes no branched N-glycans 
does not exhibit switch-like responses 
to increasing UDP-GlcNAc.
The authors use these observa-
tions as a springboard for computer 
simulations to model the ultrasensi-
tivity of Golgi N-glycan branching to 28 Cell 129, April 6, 2007 ©2007 Elseviehexosamine flux and how N-glycan 
multiplicity regulates glycoprotein 
cell-surface expression and signal-
ing. Kinetic parameters used in the 
simulations for some but not all of the 
glycosylation activities needed for N-
glycan synthesis were determined in 
vitro, and the binding constants used 
for galectin-3 were selected from a 
subset of published data. However, 
it is not clear whether these parame-
ters reflect conditions in vivo, and the 
simulations include a large number of 
assumptions. For example, although 
the presence of N-glycans that are 
more highly branched will enhance 
binding to galectins (Hirabayashi 
et al., 2002), lattice formation is a 
complex process and is not simply a 
function of binding affinities between 
galectins and N-glycans. A glycopro-
tein with three N-glycans and nine 
lactosamine units exhibits a 1000-fold 
range of galectin-3 binding constants 
(Dam et al., 2005). In addition, galec-
tin-3 oligomerizes through its N-ter-
minal domain and forms a lattice that 
has recently been visualized on the 
cell surface and that varies with cell 
state (Nieminen et al., 2007). How-
ever, excellent support for the final 
model is provided by data examining r Inc.the effects of increasing UDP-Glc-
NAc on proliferation versus growth 
arrest in NuMG mammary tumor cells 
and on surface expression of CTLA4 
in activated T cells lacking Mgat5.
The overall conclusion is that met-
abolic flux through the hexosamine 
pathway regulates UDP-GlcNAc lev-
els in the Golgi; N-glycan branching 
is ultrasensitive to increases in UDP-
GlcNAc levels; glycoprotein recep-
tors have evolved with low or high 
numbers of N-glycan sites so they 
may take advantage of differential 
N-glycan branching to regulate the 
strength of their association with a 
cell-surface galectin lattice. This in 
turn controls their rate of endocytosis 
and thereby their signaling activity. 
Arrest receptors are kept in check by 
their comparatively high rate of endo-
cytosis, due to their weak association 
with the galectin lattice and the delay 
in their response to increasing UDP-
GlcNAc. However, once the “switch” 
occurs, their cell-surface numbers 
and residence times increase, even-
tually overcoming growth-promoting 
receptors to induce arrest and differ-
entiation (Figure 1B).
The next steps are to test the model. 
A direct test would be to convert a 
growth-promoting receptor with high 
n to one with low n and show that 
hyperbolic responses to increasing 
UDP-GlcNAc become switch-like. 
This requires removing N-glycan 
sites that are not required for fold-
ing and trafficking, a feat that may be 
difficult. Another prediction would 
be that overexpression of the UDP-
GlcNAc transporter should cause all 
responses to occur at lower concen-
trations of GlcNAc. Galectin-3 and 
Mgat5 double-knockout mice should 
be investigated, although there are 
15 galectins, and redundancy may 
be a problem. The predicted differ-
ential strength of receptor associa-
tions with the galectin lattice should 
be tested directly by photobleach-
ing experiments and the galectin-
3 lattice visualized under different 
growth conditions. Finally, it will be 
important to use mass spectrometry 
with heavy isotopes to prove that the 
increase in intracellular UDP-GlcNAc 
does indeed lead to the production It has been known since the time of 
Pasteur that cells in low oxygen con-
ditions switch from aerobic to anaero-
bic metabolism. More recently, it has 
become clear that the hypoxia-induc-
ible factor 1 (HIF-1) is a key oxygen 
sensor that mediates the cell’s ability 
to cope with decreased oxygen. HIF-1 
is a transcriptional activator that is sta-
waiting to Inha
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The hypoxia-inducible factor H
oxygen conditions (hypoxia). In
functions by showing that it mof more highly branched N-glycans. 
These experiments will undoubt-
edly be forthcoming. Meanwhile, in 
an experimental tour de force, Lau 
et al. (2007) have identified a new 
paradigm for fine-tuning the regula-
tion of cell growth and differentiation 
in mammals by a mechanism that 
involves the regulation of receptor 
signaling by N-glycan site number 
and N-glycan branching controlled 
by metabolic flux.
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Fukuda et al. (2007) show that in 
hypoxic conditions, the HIF-1 tran-
scription factor regulates the replace-
ment of a key subunit of the cyto-
chrome oxidase complex (the last 
complex in the electron transport 
chain also known as complex IV) to 
maximize the efficiency of mitochon-
drial respiration. In this manner HIF-1 
spiration
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erobic respiration during low 
) expand the range of HIF-1’s 
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